Biomarin Pharmaceutical (NASDAQ:BMRN) reported quarterly earnings results on February 23, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per…
Biomarin Pharmaceutical (NASDAQ:BMRN) reported quarterly earnings results on February 23, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $0.46, beating the consensus estimate of $0.36 by $0.10 per share. Revenue came in at $875.0M, beating the estimate of $832.9M.
Biomarin Pharmaceutical's stock moved following the earnings release. The stock currently trades at $63.89 with a market capitalization of $10.2B.
Current market data
NASDAQ · BMRN
$65.68
Up: +$0.17 · +0.26%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
analyst ·
analyst ·
sec_filing ·
analyst ·
